Business Description
Orgenesis Inc
NAICS : 325412
SIC : 2834
ISIN : US68619K2042
Description
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -0.81 | |||||
| Debt-to-Equity | -0.72 | |||||
| Debt-to-EBITDA | -0.57 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -14.47 | |||||
| Beneish M-Score | -14.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -62.9 | |||||
| 3-Year EBITDA Growth Rate | 22 | |||||
| 3-Year EPS without NRI Growth Rate | 27 | |||||
| 3-Year FCF Growth Rate | 46.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.33 | |||||
| 9-Day RSI | 80.34 | |||||
| 14-Day RSI | 70.54 | |||||
| 6-1 Month Momentum % | -79.5 | |||||
| 12-1 Month Momentum % | -75.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.07 | |||||
| Quick Ratio | 0.07 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 6.98 | |||||
| Days Sales Outstanding | 65.37 | |||||
| Days Payable | 1933.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.6 | |||||
| Shareholder Yield % | -26.29 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -97.66 | |||||
| Operating Margin % | -5649.39 | |||||
| Net Margin % | -3827.81 | |||||
| FCF Margin % | -1751.17 | |||||
| ROA % | -113.92 | |||||
| ROIC % | -142.58 | |||||
| ROC (Joel Greenblatt) % | -286.15 | |||||
| ROCE % | -689.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.49 | |||||
| EV-to-EBIT | -0.79 | |||||
| EV-to-EBITDA | -0.84 | |||||
| EV-to-Revenue | 28.47 | |||||
| EV-to-FCF | -1.63 | |||||
| Earnings Yield (Greenblatt) % | -126.58 | |||||
| FCF Yield % | -143.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ORGS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orgenesis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.899 | ||
| EPS (TTM) ($) | -24.53 | ||
| Beta | 1.38 | ||
| Volatility % | 156.77 | ||
| 14-Day RSI | 70.54 | ||
| 14-Day ATR ($) | 0.26404 | ||
| 20-Day SMA ($) | 1.189225 | ||
| 12-1 Month Momentum % | -75.35 | ||
| 52-Week Range ($) | 0.87 - 10.799 | ||
| Shares Outstanding (Mil) | 5.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orgenesis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orgenesis Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Orgenesis Inc Frequently Asked Questions
What is Orgenesis Inc(ORGS)'s stock price today?
The current price of ORGS is $2.12. The 52 week high of ORGS is $10.80 and 52 week low is $0.87.
When is next earnings date of Orgenesis Inc(ORGS)?
The next earnings date of Orgenesis Inc(ORGS) is 2025-02-13 Est..
Does Orgenesis Inc(ORGS) pay dividends? If so, how much?
Orgenesis Inc(ORGS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers